<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Epidemiology of snakebite and use of antivenom in Argentina</dc:title>
  <dc:creator>Dolab, J. A.</dc:creator>
  <dc:creator>de Roodt, A. R.</dc:creator>
  <dc:creator>de Titto, E. H.</dc:creator>
  <dc:creator>Garcia, S. I.</dc:creator>
  <dc:creator>Funes, R.</dc:creator>
  <dc:creator>Salomon, O. D.</dc:creator>
  <dc:creator>/Chippaux, Jean-Philippe</dc:creator>
  <dc:subject>Antivenom</dc:subject>
  <dc:subject>Argentina</dc:subject>
  <dc:subject>Bothrops</dc:subject>
  <dc:subject>Crotalus</dc:subject>
  <dc:subject>Micrurus</dc:subject>
  <dc:subject>Snakebite</dc:subject>
  <dc:description>Background: The incidence and case fatality rate of snakebite in Argentina are poorly known. Methods: The authors used questionnaires provided with antivenoms by the primary manufacturer of anti-venoms in Argentina. Results: A total of 8083 completed questionnaires was collected between 1978 and 1998. The annual incidence of snakebite was 1.8 bites per 100 000 inhabitants, with a high geographical heterogeneity; in the northern provinces of the country, the incidence can exceed 150 snakebites per 100 000 people per year. Bothrops (pit viper) bites predominated, accounting for 96.6 (6720/6957) of envenomations, bites from Crotalus (rattlesnake) accounted for 2.8 (195/6957), and bites from Micrurus (coral snake) for 0.6 (42/6957). Most patients were young men, who were generally bitten during agricultural activities, i.e. while working in the fields. Most snakebites (78.9, 5852/7419) were to the lower limb, including 58.3 (4322/7419) to the foot. The case fatality rate was 0.04 (3/8083). Most envenomations (90, 7275/8083) were treated with specific antivenom during the first 4 h after the bite. The median dose of antivenom was two vials for viper bites (Bothrops and Crotalus) and three vials for Micrurus bites. Conclusion: These preliminary results should enable manufacturers to increase the availability of appropriate antivenom and health authorities to improve the management of snakebites where they are most common.</dc:description>
  <dc:date>2014</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010061978</dc:identifier>
  <dc:identifier>fdi:010061978</dc:identifier>
  <dc:identifier>Dolab J. A., de Roodt A. R., de Titto E. H., Garcia S. I., Funes R., Salomon O. D., Chippaux Jean-Philippe. Epidemiology of snakebite and use of antivenom in Argentina. 2014, 108 (5),  269-276</dc:identifier>
  <dc:language>EN</dc:language>
  <dc:coverage>ARGENTINE</dc:coverage>
</oai_dc:dc>
